1. Signaling networks in immunometabolism
- Author
-
Seon Ah Lim, Hongbo Chi, Jordy Saravia, Jana L. Raynor, and Nicole M. Chapman
- Subjects
T-Lymphocytes ,medicine.medical_treatment ,T cell ,Autoimmunity ,Review Article ,AMP-Activated Protein Kinases ,Protein Serine-Threonine Kinases ,Biology ,Phosphatidylinositol 3-Kinases ,03 medical and health sciences ,0302 clinical medicine ,AMP-Activated Protein Kinase Kinases ,medicine ,Animals ,Humans ,Molecular Biology ,PI3K/AKT/mTOR pathway ,030304 developmental biology ,Innate immunity ,0303 health sciences ,Innate immune system ,Effector ,Kinase ,TOR Serine-Threonine Kinases ,T-cell receptor ,Cell Biology ,Acquired immune system ,Cell biology ,Cytokine ,medicine.anatomical_structure ,030220 oncology & carcinogenesis ,Signal Transduction - Abstract
Adaptive immunity is essential for pathogen and tumor eradication, but may also trigger uncontrolled or pathological inflammation. T cell receptor, co-stimulatory and cytokine signals coordinately dictate specific signaling networks that trigger the activation and functional programming of T cells. In addition, cellular metabolism promotes T cell responses and is dynamically regulated through the interplay of serine/threonine kinases, immunological cues and nutrient signaling networks. In this review, we summarize the upstream regulators and signaling effectors of key serine/threonine kinase-mediated signaling networks, including PI3K–AGC kinases, mTOR and LKB1–AMPK pathways that regulate metabolism, especially in T cells. We also provide our perspectives about the pending questions and clinical applicability of immunometabolic signaling. Understanding the regulators and effectors of immunometabolic signaling networks may uncover therapeutic targets to modulate metabolic programming and T cell responses in human disease.
- Published
- 2020
- Full Text
- View/download PDF